Tunde Dr Tarr - Medical and Health Science Centre, University of Debrecen

基本信息

浏览量：167

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 108 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Factors of the Progression of Chronic Kidney Disease and the Development of End-Stage Renal Disease in Patients with Lupus Nephritis: A Retrospective Cohort Study

Bianka Perge,Gábor Papp, Bernadett Bói,Csilla Markóth,László Bidiga,Nikolett Farmasi,József Balla,Tünde Tarr

Journal of clinical medicineno. 3 (2025)

引用0浏览0WOS引用

P93 Investigation of Clinical and Laboratory Characteristics and Survival of SLE Patients with and Without Lupus Nephritis

Tunde Tarr, Bianka Perge, Bernadett Bói, Eszter Gáspár-Kiss,Gábor Papp

Poster presentations (2024)

引用0浏览0引用

OP0089 PHASE 2 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR Mab) ADMINISTERED EVERY 4 WEEKS UP TO 48 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Agmon-Levin N., Ignatenko S., Gordienko A.,Cortés-Hernández J.,Narongroeknawin P.,Romanowska -Prochnicka K.,Shen N.,Ciferská H., Kodera M.,Wei J.C.C.,Leszczynski P.,Lan J.L.,Mysler E.,Wojciechowski R.,Tarr T.,Vishneva E.,Chen Y.H., Kaneko Y.,Finzel S.,Hoi A.

Annals of the Rheumatic Diseases (2024): 140-142

引用0浏览0引用

Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for Up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study

Eduardo Mysler, Stanislav Ignatenko, Alexander Gordienko,Josefina Cortes-Hernandez,Nancy Agmon-Levin,Pongthorn Narongroeknawin,Katarzyna Romanowska-Prochnicka,Nan Shen,Hana Ciferska,Masanari Kodera,James Cheng-Chung Wei,Piotr Leszczynski,Joung Liang Lan,Rafal Wojciechowski,Tunde Tarr, Elena Vishneva,Yi-Hsing Chen,Yuko Kaneko,Stephanie Finzel,Alberta Hoi,Masato Okada,Ajchara Koolvisoot,Shin-Seok Lee,Lie Dai,Hiroshi Kaneko,Bernadette Rojkovich,Lingyun Sun, Eugeny Zotkin,Jean-Francois Viallard, Berta Paula Magallares,Tirtha Sengupta,Carole Sips, Carole Lau,Alexandre Avrameas,Stephen J. Oliver

ARTHRITIS & RHEUMATOLOGY (2024): 5238-5240

引用0浏览0引用

Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus

Nikolett Nagy, Bernadett Boi,Gabor Papp, Edit Fiak, Eszter Gaspar-Kiss, Bianka Perge,Nikolett Farmasi,Tuende Tarr

Biomedicinesno. 3 (2024): 530-530

引用0浏览0WOS引用

Clinical Features and Survival Analysis of Lupus Nephritis among Patients with Systemic Lupus Erythematosus: A Three-Decade-Long Retrospective Cohort Study

Bianka Perge,Gabor Papp, Bernadett Boi,Nikolett Nagy, Eszter Gaspar-Kiss,Tunde Tarr

BIOMEDICINES（2024）

引用0浏览0WOS引用

"More on the Szegedi Road" : Ten years after the death of Professor Gyula Szegedi (1936-2013)

Zoltan Szekanecz,Arpad Illes,Tunde Tarr

ORVOSI HETILAP（2023）

引用0浏览0引用

POS0120 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR Mab) ADMINISTERED MONTHLY OVER 28 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

J. Cortés-Hernández, S. Ignatenko, A. Gordienko,N. Agmon-Levin,P. Narongroeknawin,K. Romanowska -Prochnicka,N. Shen,H. Ciferská,M. Kodera,J.C.C. Wei,P. Leszczynski,J.L. Lan,R. Wojciechowski,T. Tarr,E. Vishneva,Y.H. Chen,Y. Kaneko,S. Finzel,A. Hoi,M. Okada

Annals of the Rheumatic Diseases (2023): 275-276

引用1浏览0引用

The Pathogenetic Role of Altered Microrna Expression Profiles in Circulating Follicular T Helper and B Cells in Systemic Lupus Erythematosus

Gabor Papp,Agnes Gyetvai,Szilard Poliska,Krisztina Szabo,Tunde Tarr

EUROPEAN JOURNAL OF IMMUNOLOGY (2023): 44-44

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn